Icosavax Inc (NASDAQ: ICVX) stock jumped 20.73% on Friday to $11.24 against a previous-day closing price of $9.31. With 0.54 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.25 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $11.28 whereas the lowest price it dropped to was $9.38. The 52-week range on ICVX shows that it touched its highest point at $16.45 and its lowest point at $2.29 during that stretch. It currently has a 1-year price target of $24.50. Beta for the stock currently stands at 0.87.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ICVX was up-trending over the past week, with a rise of 64.09%, but this was up by 80.42% over a month. Three-month performance surged to 47.89% while six-month performance rose 37.75%. The stock gained 360.66% in the past year, while it has gained 41.56% so far this year. A look at the trailing 12-month EPS for ICVX yields -2.22 with Next year EPS estimates of -2.11. For the next quarter, that number is -0.52. This implies an EPS growth rate of 4.69% for this year and 4.35% for next year.
Float and Shares Shorts:
At present, 41.10 million ICVX shares are outstanding with a float of 32.42 million shares on hand for trading. On Oct 30, 2023, short shares totaled 1.73 million, which was 3.45% higher than short shares on Sep 28, 2023. In addition to Mr. Adam K. Simpson as the firm’s President, CEO, Co-Founder & Director, Mr. Niranjan Kanesa-thasan M.D. serves as its Chief Medical Officer.
Through their ownership of 71.74% of ICVX’s outstanding shares, institutional investors have majority control over the company.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ICVX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ICVX analysts setting a high price target of $30.00 and a low target of $15.00, the average target price over the next 12 months is $24.50. Based on these targets, ICVX could surge 166.9% to reach the target high and rise by 33.45% to reach the target low. Reaching the average price target will result in a growth of 117.97% from current levels.
Summary of Insider Activity:
Insiders traded ICVX stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 8 while that of sell transactions has risen to 19 over the past year. The total number of shares bought during that period was 103,020 while 181,931 shares were sold.